Connection
Thomas Anchordoquy to Disease Models, Animal
This is a "connection" page, showing publications Thomas Anchordoquy has written about Disease Models, Animal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.295 |
|
|
|
-
Betker JL, Anchordoquy TJ. Assessing the effect of a nude mouse model on nanoparticle-mediated gene delivery. Drug Deliv Transl Res. 2017 02; 7(1):162-167.
Score: 0.264
-
Fogueri U, Charkoftaki G, Roda G, Tuey S, Ibrahim M, Persaud I, Wempe MF, Brown JM, Thurman JM, Anchordoquy TJ, Joy MS. An evaluation of a novel nanoformulation of imatinib mesylate in a mouse model of lupus nephritis. Drug Deliv Transl Res. 2022 06; 12(6):1445-1454.
Score: 0.022
-
Abrams DJ, Zheng L, Choo KS, Yang JJ, Wei W, Anchordoquy TJ, Zawia NH, Stevens KE. An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients. Schizophr Res. 2008 Mar; 100(1-3):86-96.
Score: 0.009